Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study Background and rationale Chronic hepatitis B is the most common cause of liver cirrhosis and hepatocellular carcinoma worldwide.(1) Antiviral therapy with oral nucleoside analogs and inter...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Long Term Follow-up of Pegylated-Interferon Alpha-2b The aim of this study was to investigate the long term outcome of Peginterferon alpha-2b with or without the addition of lamivudine in patients with chronic hepatitis B

• Pays Netherlands
• Organes Aucun
• Spécialités Aucune

48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection The purpose of this study is to investigate whether in patients with chronic HBeAg-negative hepatitis B, PEG-IFN-ribavirin combination therapy for 1 year leads to enhanced response (HBV DN...

• Pays Netherlands
• Organes Aucun
• Spécialités Aucune

PEG-IFN in HBV Patients With Incomplete Response to NA Treatment with a nucleoside analogue and subsequent viral decline has shown to partially restore immune hyporesponsiveness in chronic hepatitis B patients. Recent pilot studies investigati...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune